Controversy and consensus on antiviral treatment strategies for low-level hepatitis B surface antigens
10.3760/cma.j.cn501113-20250427-00161
- VernacularTitle:低水平乙型肝炎表面抗原抗病毒治疗策略的争论和共识
- Author:
Yihui HOU
1
;
Liaoyun ZHANG
1
Author Information
1. 山西医科大学第一医院感染病科,太原 030000
- Publication Type:Journal Article
- Keywords:
Hepatitis B virus;
Hepatitis B surface antigen;
Antiviral therapy
- From:
Chinese Journal of Hepatology
2025;33(6):521-525
- CountryChina
- Language:Chinese
-
Abstract:
Hepatitis B virus infection is a global public health issue, and there exist many controversies about the antiviral treatment strategies for patients with low-level hepatitis B surface antigen. This article reviews the definition, clinical significance, and current controversial focus of treatment strategies for low-level hepatitis B surface antigen, including treatment timing, drug selection, treatment course determination, and other aspects, while also suggesting future research directions.